SCHEMBL4726440

SCHEMBL4726440

CCCC[Sn](CCCC)(CCCC)c1[nH]c(S(=O)(=O)c2ccccc2)nc1COCC[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 6/20 0.36
CCNE2 O96020 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
ABCC1 P33527 4/20 0.34
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 3/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
FFAR2 O15552 2/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TP53 P04637 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8489958 0.79 FFAR2 (0.34) ABCB1ABCC1ALDH1A1MAPTFFAR2
SCHEMBL8488040 0.72 HTT (0.35) ABCB1TDP1ALDH1A1MAPTTSHR
SCHEMBL8492036 0.72 ABCB1 (0.32) ABCB1ABCC1ALDH1A1MAPTFFAR2
SCHEMBL8486725 0.69 ABCB1 (0.33) ABCB1ABCC1ALDH1A1MAPTTSHR
SCHEMBL4728358 0.69 AKT1 (0.36) CCNE1CDK2TDP1ALDH1A1HPGD
SCHEMBL4890258 0.68 ABCB1 (0.39) ABCB1CCNE2CCNE1CDK2ABCC1
SCHEMBL8488050 0.68 FFAR2 (0.39) FFAR2
SCHEMBL5284320 0.60 MAPK1 (0.43) TDP1MAPTTSHRLMNAHTT
SCHEMBL29669045 0.58 ALDH1A1 (0.56) TDP1ALDH1A1MAPTTSHRKDM4E
SCHEMBL6997572 0.58 NPC1 (0.39) ALDH1A1HPGDGAATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008036308-A2 AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2008-03-27 WO disclosed